Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies

European Journal of Clinical Pharmacology

Volumn 49, Issue 4, 1996, Pages 251-254

  Aarons, L ^a   Balant, L P ^b   Mentre F ^c   Morselli, P L ^d,e   Rowland, M ^a   Steimer, J L ^f   Vozeh, S ^g  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Universidad Autonoma Barcelona ^*

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f Sandoz Pharma Ltd   (Switzerland)

^g Intercantonal Office   (Switzerland)

Author keywords

Clinical trials; Drug development; Experimental design; Pharmacodynamics; Population pharmacokinetics

Indexed keywords

CLINICAL TRIAL; CONFERENCE PAPER; DRUG DEVELOPMENT; HUMAN; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0030032516     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00226323     Document Type: Conference Paper

References (1)

1. Aarons L, Balant LP, Mentré F, Morselli PL, Rowland M, Steimer J-L, Vozeh S (1994) Population approaches in drug development. Report on an expert meeting to discuss population pharmacokinetic/pharmacodynamic software. Eur J Clin Pharmacol 46: 389-391